See more : Net Lease Office Properties (NLOP) Income Statement Analysis – Financial Results
Complete financial analysis of NeoDynamics AB (publ) (NEOD.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NeoDynamics AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- CSG Systems International, Inc. (CSGS) Income Statement Analysis – Financial Results
- N. Leventeris S.A. (LEBEK.AT) Income Statement Analysis – Financial Results
- Hanjin Heavy Industries & Construction Holdings Co., Ltd. (003480.KS) Income Statement Analysis – Financial Results
- InnoCan Pharma Corporation (INNO.CN) Income Statement Analysis – Financial Results
- Exsitec Holding AB (publ) (EXS.ST) Income Statement Analysis – Financial Results
NeoDynamics AB (publ) (NEOD.ST)
About NeoDynamics AB (publ)
NeoDynamics AB (publ), a medical technology company, develops biopsy system to enhance diagnosis and care of breast cancer patients. It develops NeoNavia, a precision biopsy system that offers clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. The company was incorporated in 2015 and is based in Lidingö, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 321.00K | 134.90K | 1.16M | 17.10M | 21.79M | 0.00 | 15.14K |
| Cost of Revenue | 91.24M | 732.90K | 4.99M | -17.10M | -22.22M | -24.88M | -11.02M |
| Gross Profit | -90.92M | -598.00K | -3.82M | 34.21M | 44.01M | 24.88M | 11.04M |
| Gross Profit Ratio | -28,323.99% | -443.30% | -329.20% | 200.00% | 201.99% | 0.00% | 72,900.42% |
| Research & Development | 0.00 | 17.37M | 17.37M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 37.12M | 34.64M | 31.33M | 32.43M | 13.80M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 71.96M | 54.56M | 37.12M | 34.64M | 31.33M | 32.43M | 13.80M |
| Other Expenses | 0.00 | 72.79M | 27.47M | 11.46M | 9.32M | 8.03M | 4.70M |
| Operating Expenses | 90.97M | 72.79M | 64.59M | 46.10M | 40.66M | 40.46M | 18.50M |
| Cost & Expenses | 91.24M | 73.52M | 69.58M | 29.00M | 18.43M | 15.58M | 7.48M |
| Interest Income | 12.33K | 103.00K | 205.00 | 1.01M | 510.12K | 133.72K | 1.09K |
| Interest Expense | 3.30M | 2.99K | 205.00 | 1.01M | 540.13K | 2.71M | 5.29K |
| Depreciation & Amortization | 18.30M | 18.25M | 17.84M | -547.19K | 600.48K | 560.27K | 418.78K |
| EBITDA | -72.62M | -54.98M | -50.63M | -29.55M | -17.84M | -14.92M | -7.05M |
| EBITDA Ratio | -22,624.30% | -40,759.58% | -4,357.65% | -172.74% | -81.89% | 0.00% | -46,588.57% |
| Operating Income | -90.92M | -73.23M | -68.47M | -29.00M | -18.44M | -15.62M | -7.47M |
| Operating Income Ratio | -28,323.99% | -54,285.75% | -5,893.24% | -169.54% | -84.64% | 0.00% | -49,361.99% |
| Total Other Income/Expenses | -2.86M | 100.01K | 18.85K | -2.01M | -550.88K | -2.77M | -12.79K |
| Income Before Tax | -94.50M | -73.13M | -68.47M | -31.01M | -18.98M | -18.20M | -7.48M |
| Income Before Tax Ratio | -29,439.88% | -54,211.61% | -5,893.26% | -181.29% | -87.12% | 0.00% | -49,389.74% |
| Income Tax Expense | -1.84M | 1.38M | 205.00 | 1.01M | 540.13K | 133.72K | 1.09K |
| Net Income | -92.67M | -74.51M | -68.47M | -32.01M | -19.52M | -18.20M | -7.48M |
| Net Income Ratio | -28,867.60% | -55,237.30% | -5,893.27% | -187.17% | -89.60% | 0.00% | -49,389.74% |
| EPS | -30.21 | -62.00 | -114.00 | -103.41 | -127.56 | -208.21 | -108.00 |
| EPS Diluted | -30.21 | -62.00 | -114.00 | -103.41 | -127.56 | -208.21 | -108.00 |
| Weighted Avg Shares Out | 3.07M | 1.20M | 600.61K | 309.59K | 153.04K | 87.41K | 69.23K |
| Weighted Avg Shares Out (Dil) | 3.07M | 1.20M | 600.61K | 309.59K | 153.04K | 87.41K | 69.23K |
Source: https://incomestatements.info
Category: Stock Reports